Granisetron Hydrochloride Injection
Product Images NDC 0143-9744

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Granisetron Hydrochloride (NDC 0143-9744). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Granisetron HCl Injection 1)

Chemical structure of granisetron hydrochloride as shown, including the molecular framework and associated hydrochloride notation.*

FDA Label Image

1 mg Vial (Granisetron HCl Injection 2)

Label for Granisetron Hydrochloride Injection, USP 1 mg/mL. It is a single-dose vial for intravenous use only, labeled for prescription use. The label includes storage instructions indicating refrigeration at 20° to 25°C with allowable excursions from 15° to 30°C, warnings against freezing, and directions to protect the vial from light. The product is distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

1 mg Carton (Granisetron HCl Injection 3)

Packaging label for Granisetron Hydrochloride Injection, USP 1 mg/mL by Hikma Pharmaceuticals USA Inc. The label is for intravenous use only and contains 10 single dose vials of 1 mL each. The label includes usage instructions, storage conditions, and the manufacturer's details.*

FDA Label Image

4 mg Vial (Granisetron HCl Injection 4)

Label for Granisetron Hydrochloride Injection, USP, 4 mg per 4 mL (1 mg/mL) intravenous injection, a 4 mL multiple dose vial. The label includes storage instructions and cautions, the NDC number 0143-9745-01, and the labeler Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Ndc 0143-9745-10 10 X 4 mL Multi-use Vials Granisetron Hydrochloride Injection, Usp 4 mg/4 mL (1 mg/ml*) For Intravenous Use Only Rx Only *each mL Contains, In Sterile Aqueous Solution, Granisetron Hydrochloride, Usp, 1.12 mg, Equivalent To Gransietron, 1 mg, Sodium Chloride, Usp, 9 mg, Citric Acid, Nf, 2 mg, Benzyl Alcohol, Nf, 10 mg, As A Preservative. Ph Adjusted With Sodium Hydroxide/ Hydrochloric Acid. Usual Dosage: See Package Insert. Store At 20º To 25ºc (68º To 77ºf); Excursions Permitted To 15º To 30ºc (59º To 86ºf) [see Usp Controlled Room Temperature]. Do Not Freeze. Protect From Light. Retain In Carton Until Time Of Use. (Granisetron HCl Injection 5)

Packaging label for Granisetron Hydrochloride Injection, USP 4 mg per 4 mL (1 mg/mL) by Hikma Pharmaceuticals USA Inc. The label indicates this is a multiple dose vial intended for intravenous use only, with a package size of 5 vials, each containing 4 mL.*

FDA Label Image

Granisetron HCl Injection 6

The carton label for Granisetron Hydrochloride Injection, USP, shows a strength of 4 mg per 4 mL (1 mg/mL) in multiple 4 mL vials. It is indicated for intravenous use only. Manufactured by Hikma Farmacêutica (Portugal), distributed by Hikma Pharmaceuticals USA Inc. The label includes dosing storage instructions and highlights that the package contains 10 multiple dose vials.*

FDA Label Image

Granisetron HCl Injection 7

Label panel showing a printed QR code alongside text fields for GTIN, serial number, expiration date, and lot number. The label is associated with Granisetron Hydrochloride injection 1 mg/mL by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.